Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1972 Sept., , 1972
Use of L-Dopa in the Detection of Presymptomatic Huntington's Chorea
NEJM 286:1332, Klawans,H.,et al, 1972
Methyldopahydrazine as an Adjunct to L-Dopa Therapy in Parkinsonism
Neurol 22:384, Chase,T.,et al, 1972
Treatment of Parkinsonism
NEJM 287:1047, Young,R.R., 1972
Metabolic Responses to Acute & Chronic L-Dopa Administration in Patients with Parkinsonism
NEJM 287:729, Sirtori,C.,et al, 1972
Treatment for Parkinsonism
Other than Levodopa, BMJ 741, 1972 March., , 1972
Occurence of Positive Coombs Test in Patients Treated with Levodopa
NEJM 286:1401, Joseph,C., 1972
Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972
Presymptomatic Detection of Huntington's Chorea
BMJ 540, 1972 Sept., , 1972
Modern Treatment of Parkinson's Disease
Excerpta Medica 2:1972 Aug., , 1972
Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias
Arch Gen Psychiat 27:502-507, Rubovits,R.,et al, 1972
Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1971 Jun-Jul., , 1971
Modern Treatment of Parkinson's Disease
Excerpta Medica 2:1971 Oct., , 1971
How does L-Dopa Work in Parkinsonism
Lancet 784, 1971 Apr., Sandler,M., 1971
Modern Treatment of Parkinson's Disease
Excerpta Medica l:Nov-Dec, , 1971
Combined Treatment of Parkinsonian Tremor with Propranolol & Levodopa
J Neurol Sci 14:491, , 1971
Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971
Levodopa Therapy:Why Wait? Patient Care June 15
1971., , 1971
Manic Response to Levodopa Therapy
NEJM 285:788, Ryback,R.,et al, 1971
Dopamine & Disease
C M A Journ 103:824, Barbeau,A., 1970
Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970
L-Dopa in the Treatment of Parkinson's Disease
Postgrad Med 47:153, Martin,W., 1970
Neuropsychopharmcology & the Affective Disorders
NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969
The Phenotypic Continuum of ATP1A3-Related Disorders
Neurol 99:e1511-e1526, Vezyroglou,A., et al, 2022
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Depression, Palpitations, and Unilateral Pulsatile Tinnitus Due to a Dopamine-Secreting Glomus Jugulare Tumor
Am J Med 104:310-311, Troughton,R.W.,et al, 1998
Presynaptic Dopaminergic Deficits in Lesch-Nyhan Disease
NEJM 334:1568-1572, 16021996., Ernst,M.,et al, 1996
Dopamine, Dystonia, and the Deficient Co-Factor
Lancet 345:1130, Williams,A.C., 1995
Comparison of Striatal 18F-dopa Uptake in Adult-Onset Dystonia-Parkinsonism, Parkinson's & Dopa-Responsive Dystonia
Neurol 43:1563-1568, Turjanski,N.,et al, 1993
Evidence for a Dopaminergic Deficit in Sporadic Amyoptrophic Lateral Sclerosis on Positron Emission Scanning
Lancet 324:1016-1018, Takahashi,H.,et al, 1993
Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985
Skin Rash Associated with Sinemet 25/100
NEJM 309:1387-1388, Goetz,C.G., 1983
Sinemet-25/100
Medical Letter, 22:511980., , 1980
Alzheimer's Disease
Editorial, BMJ 281:1374-13751980., , 1980
Exacerbation of Parkinsonism by Methyldopa
JAMA 244:2727-2728, Rosenblum,A.M.&Montgomery,E.B., 1980
Dopamine-Phenytoin Interaction, A Cause of Hypotension in the Critically Ill
Arch Surg 113:245-249, Bivins,B.A.,et al, 1978
Long-term Therapy of Myoclonus & Other Neurologic Disorders with L-5-Hydroxytryptophan & Carbidopa
NEJM 296:70, VanWoert,M.H.,et al, 1977
Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome
NEJM 296:210, VanWoert,M.H.,et al, 1977
Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977
Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974
Facial Hyperkinesis
BMJ 626, Jun1974., , 1974
Cholinergic & Dopaminergic Mechanisms in Huntington's Chorea
Life Sciences 10:405 1971., Aquilonius,S.,et al, 1971
Long-Term Consumption of Ultraprocessed Foods and Prodromal Features of Parkinson Disease
Neurol 104:e213562, Wang,P.,et al, 2025
Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025
Methamphetamine-Induced Basal Ganglia Toxicity Presenting as Parkinsonism
Neurol 104:e213365, Yi,M.Y.,et al, 2025
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
Neurol 103:e209805, Kim,H.K.,et al, 2024
Rabbit Syndrome
Neurol102:e209275, Huynh,T.U., & Beckley, E.H., 2024
Association of Coffee Consumption and Prediagnostic Caffeine Metabolites with Incident Parkinson Disease in a Population-Based Cohort
Neurol 102:e209201, Zhao,Y.,et al, 2024
Treatment Modalities and Outcomes in Brainstem Cavernous Malformations: A Large Multicenter Observational Cohort Study
Stroke 55:1151-1160, Lu,J.,et al, 2024
Vascular Malformations of the Central Nervous System
www.UptoDate.Com, March, Singer,R.J.,et al, 2024